Home
/ Citryll
/ Competitors

Citryll Competitors and Similar CompaniesClear all

Citryll's competitors and similar companies include Anavex, Clover Biopharmaceuticals, Vericel and Orbsen Therapeutics.

	Citryll Citryll is a pharmaceutical company engaged in the treatment of autoimmune and some other human diseases with the help of tACPA program	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	Clover Biopharmaceuticals Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing novel and transformative biologic therapies.	Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.	Orbsen Therapeutics Orbsen Therapeutics is a company that specializes in the development of regenerative medicine therapies.
Founding Date	Founding Date 2019	Founding Date 2006	Founding Date 2007	Founding Date 1989	Founding Date 2006
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research therapy	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare biotech clinical research therapy	Tags Healthcare biotech clinical research therapy	Tags Healthcare biotech clinical research therapy
Locations	Locations Oss, NL HQ	Locations New York, US HQ Reno, US	Locations Shanghai, CN HQ Beijing, CN Chengdu, CN Huzhou, CN Boston, US	Locations Cambridge, US HQ Ann Arbor, US	Locations HQ
Employees	Employees 313% increase	Employees 1623% increase	Employees 1591% decrease	Employees 24112% increase	Employees 10
Valuation ($)	Valuation ($) N/A	Valuation ($) 484.6 m	Valuation ($) N/A	Valuation ($) 2.2 b	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income ($46.4m) (FY, 2025)	Net income N/A	Net income $16.5m (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 23m (almost 6 years ago)	Latest funding round N/A	Latest funding round $ 230m (about 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 39.9m	Total funding raised $ 12.6m	Total funding raised $ 306.7m	Total funding raised N/A	Total funding raised N/A